Multidisciplinary Treatment of Advanced Hepatocellular Carcinoma

Current strategy for treatment of hepatocellular carcinoma (HCC) based on Barcelona-Clinic Liver Cancer (BCLC) criteria dictates that patients with advanced-stage HCC are to only receive treatment with tyrosine kinase inhibitors. However, they prolong overall survival just by slightly more than 6 mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhe, Abdrakhimov, Bulat, Wang, Shuo, Xie, Qin-Fen, Zheng, Shu-Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098351/
https://www.ncbi.nlm.nih.gov/pubmed/32231509
http://dx.doi.org/10.1159/000506185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098351/
https://www.ncbi.nlm.nih.gov/pubmed/32231509
http://dx.doi.org/10.1159/000506185

Ejemplares similares